The pattern of sensitivity in MEKi-sensitive lines was similar to what is seen in DBTRG, a GBM cell line with the BRAF V600E mutation, which confers ERK dependence and sensitivity to MEK inhibition (Figure 4).35 This evidence concerns the gene MAP2K7 and glioblastoma.